• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.系统性硬化症患者输注伊洛前列素后指端血流持续增加。
Postgrad Med J. 1987 Aug;63(742):617-20. doi: 10.1136/pgmj.63.742.617.
2
Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.静脉输注伊洛前列素与口服硝苯地平治疗系统性硬化症患者雷诺现象的比较:一项双盲随机研究。
BMJ. 1989 Mar 4;298(6673):561-4. doi: 10.1136/bmj.298.6673.561.
3
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.静脉注射伊洛前列素治疗系统性硬化症继发的雷诺现象和缺血性溃疡。
J Rheumatol. 1992 Sep;19(9):1407-14.
4
Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.输注伊洛前列素(一种前列环素类似物)用于治疗系统性硬化症中的雷诺现象。
Ann Rheum Dis. 1988 Jan;47(1):43-7. doi: 10.1136/ard.47.1.43.
5
Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue.用伊洛前列素(一种化学性质稳定的前列环素类似物)成功治疗雷诺综合征。
Br J Rheumatol. 1988 Jun;27(3):220-6. doi: 10.1093/rheumatology/27.3.220.
6
Treatment of ischaemic digital ulcers and prevention of gangrene with intravenous iloprost in systemic sclerosis.在系统性硬化症中,使用静脉注射伊洛前列素治疗缺血性指端溃疡并预防坏疽。
Acta Derm Venereol. 1996 May;76(3):236-8. doi: 10.2340/0001555576236238.
7
Evidence for increase in finger blood flow, evaluated by laser Doppler flowmetry, following iloprost infusion in patients with systemic sclerosis: a week-long observational longitudinal study.在系统性硬化症患者中,通过激光多普勒血流仪评估发现,静脉输注伊洛前列素后手指血流量增加的证据:一项为期一周的观察性纵向研究。
Scand J Rheumatol. 2018 Jul;47(4):311-318. doi: 10.1080/03009742.2017.1397187. Epub 2018 Feb 7.
8
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study.静脉输注伊洛前列素治疗系统性硬化症继发雷诺现象。一项多中心、安慰剂对照、双盲研究。
Ann Intern Med. 1994 Feb 1;120(3):199-206. doi: 10.7326/0003-4819-120-3-199402010-00004.
9
[Treatment of Raynaud's phenomenon in scleroderma with a new stable prostacyclin derivative].
Dtsch Med Wochenschr. 1984 Sep 21;109(38):1433-8. doi: 10.1055/s-2008-1069390.
10
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany].[德国系统性硬化症所致肢端循环障碍患者住院使用前列环素衍生物进行血管活性治疗的实际情况]
Z Rheumatol. 2020 Dec;79(10):1057-1066. doi: 10.1007/s00393-019-00743-9.

引用本文的文献

1
Real life use of prostacyclin analog (iloprost), a multi-centric survey data from the Scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature.前列环素类似物(依前列醇)的实际应用:来自艾米利亚-罗马涅硬皮病研究组(Sclero-RER)的多中心调查数据和文献复习。
Acta Biomed. 2023 Aug 3;94(4):e2023148. doi: 10.23750/abm.v94i4.14317.
2
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review.系统性硬皮病患者的系统性药理学治疗:系统文献回顾。
Rheumatology (Oxford). 2023 Dec 1;62(12):3785-3800. doi: 10.1093/rheumatology/kead289.
3
Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms.雷诺现象:潜在机制的简要综述
Front Pharmacol. 2016 Nov 16;7:438. doi: 10.3389/fphar.2016.00438. eCollection 2016.
4
Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries.包载前列环素的脂质体纳米粒在肺动脉中表现出增强的血管舒张作用。
Int J Nanomedicine. 2014 Jul 7;9:3249-61. doi: 10.2147/IJN.S63190. eCollection 2014.
5
[Therapeutic management in early disease stages of systemic sclerosis : early diagnosis - early symptoms - early problems].系统性硬化症疾病早期阶段的治疗管理:早期诊断 - 早期症状 - 早期问题
Z Rheumatol. 2013 Dec;72(10):960-9. doi: 10.1007/s00393-013-1270-2.
6
Large leg ulcers due to autoimmune diseases.由于自身免疫性疾病导致的大型腿部溃疡。
Med Sci Monit. 2011 Jan;17(1):CS1-7. doi: 10.12659/msm.881308.
7
The ILAILL study: iloprost as adjuvant to surgery for acute ischemia of lower limbs: a randomized, placebo-controlled, double-blind study by the italian society for vascular and endovascular surgery.ILAIL研究:伊洛前列素作为下肢急性缺血手术的辅助治疗:意大利血管和血管内手术学会进行的一项随机、安慰剂对照、双盲研究
Ann Surg. 2006 Aug;244(2):185-93. doi: 10.1097/01.sla.0000217555.49001.ca.
8
[Treatment of therapy-resistant acral ulcers with iloprost].
Hautarzt. 2004 Dec;55(12):1150-3. doi: 10.1007/s00105-004-0844-y.
9
Long-term evaluation of lung function in patients affected by scleroderma treated with cyclic iloprost infusions.
Rheumatol Int. 2005 May;25(4):250-4. doi: 10.1007/s00296-004-0439-z. Epub 2004 Feb 13.
10
[Iloprost therapy in systemic sclerosis].[伊洛前列素治疗系统性硬化症]
Hautarzt. 2003 Sep;54(9):845-51. doi: 10.1007/s00105-003-0578-2.

本文引用的文献

1
Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2).通过静脉输注前列环素(PGI2)治疗雷诺现象。
Br J Dermatol. 1982 Jan;106(1):81-9. doi: 10.1111/j.1365-2133.1982.tb00905.x.
2
Vascular endothelial cell injury in progressive systemic sclerosis and other connective tissue diseases.
Clin Exp Rheumatol. 1983 Jan-Mar;1(1):29-34.
3
Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.
Lancet. 1983 Feb 12;1(8320):315-7. doi: 10.1016/s0140-6736(83)91625-2.
4
Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.雷尼尔氏综合征患者间歇性输注依前列醇(前列环素):一项双盲对照试验。
Lancet. 1983 Feb 12;1(8320):313-5. doi: 10.1016/s0140-6736(83)91624-0.
5
CL115,347, an analogue of prostaglandin E2. Peripheral circulatory effects of single ascending doses administered transdermally in normal subjects and in patients with Raynaud's phenomenon.CL115,347,一种前列腺素E2类似物。在正常受试者和雷诺现象患者中经皮单次递增剂量给药的外周循环效应。
Angiology. 1985 Dec;36(12):867-71. doi: 10.1177/000331978503601205.
6
Photoplethysmography of the distal pulp in the assessment of the vasospastic hand.用于评估血管痉挛性手部的指腹光电容积脉搏波描记法
Angiology. 1985 Jan;36(1):33-40. doi: 10.1177/000331978503600106.
7
Prostaglandin E1 vasospastic disease and thermography.前列腺素E1、血管痉挛性疾病与热成像
Ann Rheum Dis. 1985 Feb;44(2):73-8. doi: 10.1136/ard.44.2.73.
8
Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.猪主动脉内皮细胞中前列环素和内皮源性舒张因子(EDRF)的生物测定
Br J Pharmacol. 1986 Apr;87(4):685-94. doi: 10.1111/j.1476-5381.1986.tb14586.x.
9
Treatment of childhood Raynaud's disease by transdermal prostaglandin E2 analogue.
Lancet. 1985 Jul 6;2(8445):50. doi: 10.1016/s0140-6736(85)90108-4.
10
Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man.
Thromb Haemost. 1985 Feb 18;53(1):90-4.

系统性硬化症患者输注伊洛前列素后指端血流持续增加。

Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.

作者信息

Rademaker M, Thomas R H, Provost G, Beacham J A, Cooke E D, Kirby J D

机构信息

Department of Dermatology, St Bartholomew's Hospital, West Smithfield, London, UK.

出版信息

Postgrad Med J. 1987 Aug;63(742):617-20. doi: 10.1136/pgmj.63.742.617.

DOI:10.1136/pgmj.63.742.617
PMID:2447572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2428395/
Abstract

Thirteen patients with Raynaud's phenomenon secondary to systemic sclerosis received three 8-hour infusions of a synthetic prostacyclin analogue (Iloprost) on consecutive days and were followed-up over a period of 10 weeks during the winter of 1985/86. Six weeks after infusion, digital peripheral vascular resistance had fallen (P less than 0.05) and dicrotic notch proportion of pulse amplitude increased (P less than 0.05). Digital blood flow and pulse amplitude (measured by photoplethymography) were also increased but did not reach statistical significance. The trend of improvement in these blood flow parameters was still evident after 10 weeks. The number of cutaneous lesions (digital ulcers, etc) fell from 26 lesions before infusion to only 7 lesions by the end of the study, confirming the subjective improvement reported by the patients.

摘要

13例继发于系统性硬化症的雷诺现象患者在连续3天接受了3次8小时的合成前列环素类似物(依洛前列素)静脉输注,并于1985/1986年冬季进行了为期10周的随访。输注6周后,指端外周血管阻力下降(P<0.05),脉搏波幅的重搏波切迹比例增加(P<0.05)。指端血流和脉搏波幅(通过光电容积描记法测量)也有所增加,但未达到统计学显著性。10周后这些血流参数的改善趋势仍然明显。皮肤病变(指端溃疡等)的数量从输注前的26处减少至研究结束时仅7处,证实了患者报告的主观改善情况。